One other identified compound in this group—the glycosidic flavonoid tiliroside, has a wide nutraceutical profile, due to its antioxidant and anti-inflammatory activities [48], demonstrating antidiabetic, anti-obesity, hepatoprotective, and lipid-lowering effects, partly through the modulation of adiponectin signaling and inhibition of key inflammatory pathways [49,50,51]. The gene discussed is ADIPOQ; the disease is Obesity.